Clinical Trial Update: Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating erythrocyte-mediated delivery of dexamethasone 21-phosphate for steroid-dependent ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Dexamethasone 21-phosphate (dexamethasone 21-phosphate)

Snippet

Sponsor: Quince Therapeutics S.p.A. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2024-09-24